Effect of lung allograft ischaemia duration on postreperfusion graft function and postoperative course

被引:11
作者
Bund, M
Struber, M
Heine, J
Jaeger, K
Wahlers, T
Haverich, A
Piepenbrock, S
机构
[1] Med Hsch Hannover, Dept Anaesthesiol, D-30625 Hannover, Germany
[2] Med Hsch Hannover, Dept Thorac & Cardiovasc Surg, D-30625 Hannover, Germany
关键词
Euro-Collins solution; ischaemia; lung transplantation; organ preservation;
D O I
10.1055/s-2007-1010197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lung transplantation is limited by the effects of ischaemia, Previous clinical studies related graft ischaemia duration to postoperative pulmonary function in the ICU, morbidity, and overall survival. This report describes the intraoperative pulmonary allograft function immediately after reperfusion. 23 lung transplantations (15 bilateral, 8 single) were analysed. Donor selection and organ procurement were identical. After pulmonary vasodilation with prostacyclin, allografts were flush-perfused with cold modified Euro-Collins solution. Mean duration of lung ischaemia was 255.1 +/- 35.1 min (190-314 min). Ischaemia times did not differ with respect to the recipient's disease or the use of extracorporeal circulation. After reperfusion, oxygenation indices deteriorated in 73.9% of patients compared with the native lungs (313.4 +/- 163.5 vs 427.2 +/- 96.1, p = 0.006). Linear regression analysis and subgroup analysis both revealed a significant influence of the duration of allograft ischaemia on early transplant function. Ischaemia of more than 4 hours resulted in an acceptable but significantly lower PaO2 (254.9 +/- 143.3 mmHg vs 463.0 +/- 149.2 mmHg, p = 0.011), However, mean time until extubation and time spent in the ICU were not affected. It is concluded that flush-perfusion of the lung with modified Euro-Collins solution provides reliable preservation of lung function up to four hours. Longer ischaemia, up to six hours, is followed by an acceptable but progressively reduced early transplant function.
引用
收藏
页码:93 / 96
页数:4
相关论文
共 20 条
[1]   INHALED NITRIC-OXIDE IN THE TREATMENT OF POSTOPERATIVE GRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION [J].
ADATIA, I ;
LILLIHEI, C ;
ARNOLD, JH ;
THOMPSON, JE ;
PALAZZO, R ;
FACKLER, JC ;
WESSEL, DL .
ANNALS OF THORACIC SURGERY, 1994, 57 (05) :1311-1318
[2]   ANAESTHESIOLOGIC MANAGEMENT OF COMBINED LUNG AND LIVER-TRANSPLANTATION [J].
BUND, M ;
SEITZ, W ;
SCHAFERS, HJ ;
RINGE, B ;
KIRCHNER, E .
ANAESTHESIST, 1994, 43 (05) :322-329
[3]  
BURDINE J, 1991, TRANSPLANT P, V23, P1176
[4]   PULMONARY TRANSPLANTATION [J].
DAVIS, RD ;
PASQUE, MK .
ANNALS OF SURGERY, 1995, 221 (01) :14-28
[5]   Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation [J].
Hausen, B ;
Rohde, R ;
Hewitt, CW ;
Schroeder, F ;
Beuke, M ;
Ramsamooj, R ;
Schafers, HJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (06) :1050-1058
[6]  
HAVERICH A, 1996, CHIRURG OPERATIONSLE, V12, P96
[7]  
Hosenpud JD, 1996, J HEART LUNG TRANSPL, V15, P655
[8]  
KEENAN RJ, 1991, J HEART LUNG TRANSPL, V10, P650
[9]  
Kshettry VR, 1996, J HEART LUNG TRANSPL, V15, P169
[10]  
NOVICK RJ, 1992, J HEART LUNG TRANSPL, V11, P377